Ligand validation:3V8C

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3V8C designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3V8C_NAG_A_501	49%	42%	0.142	0.902	0.66	1.57	-	2	5	0	93%	0.9333
3V8C_NAG_A_505	43%	39%	0.201	0.936	0.83	1.52	-	3	7	0	93%	0.9333
3V8C_NAG_B_505	34%	24%	0.189	0.884	0.51	2.55	-	7	3	0	93%	0.9333
3V8C_NAG_A_502	30%	31%	0.213	0.891	0.9	1.82	1	4	9	0	93%	0.9333
3V8C_NAG_A_508	14%	15%	0.192	0.754	0.68	3.03	-	8	4	0	93%	0.9333
3V8C_NAG_B_501	0%	60%	0.446	0.491	0.51	1.02	-	-	0	0	93%	0.9333
3V8C_NAG_B_502	0%	51%	0.479	0.387	0.7	1.17	-	2	3	0	93%	0.9333
4X4M_NAG_D_1001	99%	17%	0.043	0.979	1.61	1.99	3	6	13	0	100%	0.9333
7URU_NAG_C_1002	72%	76%	0.124	0.947	0.55	0.41	-	-	1	0	100%	0.9333
4ACP_NAG_B_1446	56%	56%	0.146	0.918	0.64	1.05	-	1	0	0	100%	0.9333
5XJF_NAG_C_1001	43%	44%	0.191	0.913	0.83	1.32	-	2	0	0	100%	0.9333
3WJL_NAG_C_1001	35%	52%	0.225	0.916	0.56	1.27	-	3	0	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3GXM_NAG_A_498	100%	45%	0.026	0.992	0.75	1.34	-	2	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.